European Commission has approved Keytruda in combination with carboplatin and either paclitaxel or nab-paclitaxel, for the first-line treatment of adults with metastatic squamous non-small cell lung cancer.
Elizabeth Comen originally set out to write a book about the wellness industry, but ended up writing a different book altogether.
